Thin film nitinol demonstrates promising hemodynamic and biocompatibility profiles in early preclinical testing, suggesting potential suitability for artificial heart valves.
Answers are grounded in this paper and cite their sources.
Supports further preclinical testing of thin film nitinol valves; leaves open translation to clinical use.
In order to create a less thrombogenic heart valve with improved longevity, a prosthetic heart valve was developed using thin film nitinol (NiTi). A "butterfly" valve was constructed using a single, elliptical piece of thin film NiTi and a scaffold made from Teflon tubing and NiTi wire. Flow tests and pressure readings across the valve were performed in vitro in a pulsatile flow loop. Bio-corrosion experiments were conducted on untreated and passivated thin film nitinol. To determine the material's in vivo biocompatibility, thin film nitinol was implanted in pigs using stents covered with thin film NiTi. Flow rates and pressure tracings across the valve were comparable to those through a commercially available 19 mm Perimount Edwards tissue valve. No signs of corrosion were present on thin film nitinol samples after immersion in Hank's solution for one month. Finally, organ and tissue samples explanted from four pigs at 2, 3, 4, and 6 weeks after thin film NiTi implantation appeared without disease, and the thin film nitinol itself was without thrombus formation. Although long term testing is still necessary, thin film NiTi may be very well suited for use in artificial heart valves.
No takes yet. Share an insight, caveat, or question.
Stepan et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: